Repro Med Systems Stock Buy Hold or Sell Recommendation
| KRMD Stock | USD 3.58 0.07 1.92% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Repro Med Systems is 'Strong Sell'. Macroaxis provides Repro Med buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KRMD positions.
Check out Repro Med Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Repro and provide practical buy, sell, or hold advice based on investors' constraints. Repro Med Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Repro |
Execute Repro Med Buy or Sell Advice
The Repro recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Repro Med Systems. Macroaxis does not own or have any residual interests in Repro Med Systems or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Repro Med's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Solid | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Repro Med Trading Alerts and Improvement Suggestions
| Repro Med Systems appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (13.74 M) with profit before overhead, payroll, taxes, and interest of 15.37 M. | |
| Repro Med Systems currently holds about 18.27 M in cash with (4.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Latest headline from news.google.com: KRMD stock touches 52-week high at 3.41 amid robust growth - Investing.com Australia |
Repro Med Returns Distribution Density
The distribution of Repro Med's historical returns is an attempt to chart the uncertainty of Repro Med's future price movements. The chart of the probability distribution of Repro Med daily returns describes the distribution of returns around its average expected value. We use Repro Med Systems price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Repro Med returns is essential to provide solid investment advice for Repro Med.
| Mean Return | 0.79 | Value At Risk | -4.4 | Potential Upside | 6.37 | Standard Deviation | 3.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Repro Med historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Repro Stock Institutional Investors
| Shares | Boothbay Fund Management, Llc | 2024-06-30 | 267.2 K | Blackrock Inc | 2024-06-30 | 186.8 K | State Street Corp | 2024-06-30 | 126.7 K | White Pine Capital Llc | 2024-09-30 | 125.7 K | Alpine Partners Vi, Llc | 2024-06-30 | 107.2 K | Washington Trust Co | 2024-09-30 | 100 K | Renaissance Technologies Corp | 2024-09-30 | 98.1 K | Pnc Financial Services Group Inc | 2024-09-30 | 97 K | Jane Street Group Llc | 2024-06-30 | 93.9 K | First Light Asset Management, Llc | 2024-06-30 | 5 M | Vanguard Group Inc | 2024-09-30 | 1.8 M |
Repro Med Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (284.6K) | (4.4M) | 723.4K | (298.5K) | 2.9M | 3.1M | |
| Change In Cash | 2.1M | 21.4M | (2.0M) | (7.9M) | (5.9M) | (5.6M) | |
| Free Cash Flow | (104.9K) | (1.8M) | (4.7M) | (8.2M) | (5.7M) | (5.4M) | |
| Depreciation | 340.2K | 418.6K | 463.1K | 587.1K | 870.4K | 913.9K | |
| Capital Expenditures | 425.5K | 1.1M | 375.2K | 2.8M | 814.6K | 433.9K | |
| Net Income | 564.3K | (1.2M) | (4.6M) | (8.7M) | (13.7M) | (13.1M) | |
| End Period Cash Flow | 5.9M | 27.3M | 25.3M | 17.4M | 11.5M | 12.1M | |
| Other Non Cash Items | (56.4K) | 1.3M | (1.0K) | 212.5K | 6.0M | 6.3M | |
| Investments | 1.3M | (1.0M) | (366.2K) | (2.8M) | (814.6K) | (855.3K) | |
| Change To Netincome | 961.6K | 3.0M | 890.6K | 1.1M | 1.2M | 882.4K |
Repro Med Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Repro Med or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Repro Med's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Repro stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.77 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 3.48 | |
Ir | Information ratio | 0.20 |
Repro Med Volatility Alert
Repro Med Systems shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Repro Med's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Repro Med's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Repro Med Fundamentals Vs Peers
Comparing Repro Med's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Repro Med's direct or indirect competition across all of the common fundamentals between Repro Med and the related equities. This way, we can detect undervalued stocks with similar characteristics as Repro Med or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Repro Med's fundamental indicators could also be used in its relative valuation, which is a method of valuing Repro Med by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Repro Med to competition |
| Fundamentals | Repro Med | Peer Average |
| Return On Equity | -0.5 | -0.31 |
| Return On Asset | -0.14 | -0.14 |
| Profit Margin | (0.38) % | (1.27) % |
| Operating Margin | (0.14) % | (5.51) % |
| Current Valuation | 162.74 M | 16.62 B |
| Shares Outstanding | 45.84 M | 571.82 M |
| Shares Owned By Insiders | 6.29 % | 10.09 % |
| Shares Owned By Institutions | 54.38 % | 39.21 % |
| Number Of Shares Shorted | 486.92 K | 4.71 M |
| Price To Earning | 11.56 X | 28.72 X |
| Price To Book | 9.43 X | 9.51 X |
| Price To Sales | 5.32 X | 11.42 X |
| Revenue | 28.52 M | 9.43 B |
| Gross Profit | 15.37 M | 27.38 B |
| EBITDA | (9.4 M) | 3.9 B |
| Net Income | (13.74 M) | 570.98 M |
| Cash And Equivalents | 18.27 M | 2.7 B |
| Cash Per Share | 0.41 X | 5.01 X |
| Total Debt | 4.45 M | 5.32 B |
| Debt To Equity | 0.14 % | 48.70 % |
| Current Ratio | 5.40 X | 2.16 X |
| Book Value Per Share | 0.45 X | 1.93 K |
| Cash Flow From Operations | (4.89 M) | 971.22 M |
| Short Ratio | 11.67 X | 4.00 X |
| Earnings Per Share | (0.26) X | 3.12 X |
| Target Price | 4.1 | |
| Number Of Employees | 82 | 18.84 K |
| Beta | 0.41 | -0.15 |
| Market Capitalization | 164.1 M | 19.03 B |
| Total Asset | 28.46 M | 29.47 B |
| Retained Earnings | (23.31 M) | 9.33 B |
| Working Capital | 15.8 M | 1.48 B |
| Current Asset | 2.54 M | 9.34 B |
Note: Disposition of 721781 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3 [view details]
Repro Med Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Repro . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Repro Med Buy or Sell Advice
When is the right time to buy or sell Repro Med Systems? Buying financial instruments such as Repro Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Repro Med in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Momentum Thematic Idea Now
Momentum
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Repro Med Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (0.26) | Revenue Per Share 0.674 | Quarterly Revenue Growth 0.215 | Return On Assets (0.14) |
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.